文献速递肝病

生活质量评估可预测肝硬化伴严重腹水患者的死亡风险

Quality of life measures predict mortality in patients with cirrhosis and severe ascites.
PubMed 文献 · Aliment Pharmacol Ther · 2018-12-25

该研究回顾性分析了既往随机对照试验中496例完成SF-36量表的严重腹水患者,其中405例数据完整者纳入分析。结果显示,SF-36生理成分评分(PCS)较低与死亡风险独立相关,PCS每增加10分,全因死亡风险比为0.83(95%CI 0.72-0.97),肝硬化相关死亡风险比为0.84(95%CI 0.71-0.99)。

要点

  • 严重腹水患者SF-36生理成分评分(PCS)普遍较差。
  • PCS每增加10分,全因死亡风险比为0.83(95%CI 0.72-0.97)。
  • PCS是严重腹水患者12个月死亡的独立预测因素。

核心结论

  • SF-36生理成分评分(PCS)较差是严重腹水患者12个月死亡的独立预测因素,且独立于现有预后临床评分。
  • PCS有望用于预后建模以及作为针对腹水治疗评估的终点指标。

研究设计与样本

  • 回顾性评估既往已发表的随机对照试验中接受satavaptan治疗腹水的患者的生活质量数据。
  • 496例随机化患者中完成SF-36量表者,405例数据完整者纳入分析(难治性腹水164例,顽固性腹水241例)。

主要发现

  • 患者报告生活质量差,尤其是SF-36的生理成分评分(PCS)。
  • PCS与SF-36心理成分评分(MCS)相关(Spearman秩相关系数=0.68),但与肝病严重程度标志物不相关。
  • 死亡患者的PCS显著低于存活者(P=0.01),而MCS在死亡与存活患者间无显著差异(P=0.84)。
  • 混杂因素校正后,PCS每增加10分,全因死亡风险比为0.83(95%CI 0.72-0.97),肝硬化相关死亡风险比为0.84(95%CI 0.71-0.99)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Severe ascites is associated with both a poor health-related quality of life (HRQL) and a mortality in excess of that captured by current prognostic clinical scores. AIM: To determine the association between HRQL and mortality in patients with severe ascites. METHODS: The HRQL data from previously published randomised controlled trials examining the efficacy of satavaptan in ascites were retrospectively evaluated. RESULTS: Of the 496 patients randomised who completed the SF-36, 405 patients had complete datasets and were included in the analysis (difficult-to-treat ascites, n = 164 or refractory ascites, n = 241). Overall, patients reported poor HRQL, in particular the physical component score (PCS) of SF-36. The physical component score (PCS) correlated with the mental component score (MCS) of SF-36 (Spearman rank correlation = 0.68) but not with markers of severity of liver disease. The PCS, but not the MCS, was significantly lower in patients who died (P = 0.01 and P = 0.84, respectively). After confounder-adjustment, the hazard ratio for a 10-point increase in the physical component score was 0.83 (95% CI; 0.72-0.97) for all-cause mortality and 0.84 (95% CI; 0.71-0.99) for cirrhosis-related deaths only, indicating that patients with better physical HRQL live longer on average. CONCLUSIONS: Poor physical component score (PCS) of SF-36 is an independent predictor of 12-month mortality in patients with severe ascites independent of current prognostic clinical scores. It holds promise not only in prognostic modelling but also as an endpoint in the evaluation of therapies targeting ascites.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Macdonald S, Jepsen P, Alrubaiy L, et al. Quality of life measures predict mortality in patients with cirrhosis and severe ascites. Aliment Pharmacol Ther. 2018. PMID: 30585338. doi:10.1111/apt.15084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。